Suven Life Sciences Completes Phase 1 Study of SUVN-I6107
MM Desk
23 June, 2026
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company focused on therapies for central nervous system
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company focused on therapies for central nervous system
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company focused on developing innovative therapies for central
Suven Life Sciences has announced encouraging progress in its ongoing global Phase 3 clinical study